1. The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting
- Author
-
Tiscia, Giovanni, Favuzzi, Giovanni, Laurenzo, Antonio De, Cappucci, Filomena, Fischetti, Lucia, Colaizzo, Donatella, Chinni, Elena, Florio, Lucia, Miscio, Giuseppe, Piscitelli, Angela Pamela, Mastroianno, Mario, Grandone, Elvira, and Group, on behalf of the CSS COVID-19 Group on behalf of the CSS COVID-19
- Subjects
Medicine (General) ,medicine.medical_specialty ,Endothelium ,endothelium ,Clinical Biochemistry ,von Willebrand factor ,Gastroenterology ,Article ,law.invention ,R5-920 ,Von Willebrand factor ,law ,Internal medicine ,hemic and lymphatic diseases ,medicine ,Endothelial dysfunction ,ADAMTS-13 ,Prospective cohort study ,biology ,business.industry ,ADAMTS ,COVID-19 ,fatalities ,medicine.disease ,Intensive care unit ,medicine.anatomical_structure ,Cohort ,biology.protein ,business ,Cohort study - Abstract
Background: Endothelial dysfunction, coupled with inflammation, induces thrombo-inflammation. In COVID-19, this process is believed to be associated with clinical severity. Von Willebrand factor (VWF), and a disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAMTS-13), are strong markers of endothelial dysfunction. We evaluated the impact of the VWF/ADAMTS-13 fraction on COVID-19 severity and prognosis. Materials and methods: A cohort study including 74 COVID-19 patients, with 22 admitted to the intensive care unit (ICU) and 52 to the medical ward (MW), was carried out. We also evaluated, in a group of 54 patients who were prospectively observed, whether variations in VWF/ADAMTS-13 correlated with the degree of severity and routine blood parameters. Results: A VWF:RCo/ADAMTS-13 fraction above 6.5 predicted in-hospital mortality in the entire cohort. At admission, a VWF:RCo/ADAMTS-13 fraction above 5.7 predicted admission to the ICU. Furthermore, the VWF:RCo/ADAMTS-13 fraction directly correlated with C-reactive protein (CRP) (Spearman r: 0.51, p <, 0.0001) and D-dimer (Spearman r: 0.26, p = 0.03). In the prospective cohort, dynamic changes in VWF:RCo/ADAMTS-13 and the CRP concentration were directly correlated (Spearman r, p = 0.0014). This relationship was significant in both groups (ICU: p = 0.006, MW: p = 0.02).Conclusions: The present findings show that in COVID-19, the VWF/ADAMTS-13 fraction predicts in-hospital mortality. The VWF/ADAMTS-13 fraction may be a helpful tool to monitor COVID-19 patients throughout hospitalization.
- Published
- 2021